Patent · US Active

De novo designed hemagglutinin binding proteins

US10766929B2 · kind B2 · utility

0Cited by
2References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2018
Grant dateSep 8, 2020
Priority date
Expiry dateMar 15, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Polypeptides that bind to viral hemagglotinin are disclosed and methods for their use in treating or limiting influenza infection, and diagnosing influenza infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.